Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy

AIM: To investigate the survival impact of clinicopathological factors, including pathological complete response (pCR) and tumor-infiltrating lymphocytes (sTIL) levels according to subtypes, in breast cancer (BC) patients who received neo-adjuvant chemotherapy (NAC). METHODS: We evaluated 435 BC pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Clin Oncol
Autors principals: Galvez, Marco, Castaneda, Carlos A, Sanchez, Joselyn, Castillo, Miluska, Rebaza, Lia Pamela, Calderon, Gabriela, Cruz, Miguel De La, Cotrina, Jose Manuel, Abugattas, Julio, Dunstan, Jorge, Guerra, Henry, Mejia, Omar, Gomez, Henry L
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2018
Matèries:
Observational Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893995/
https://ncbi.nlm.nih.gov/pubmed/29651385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v9.i2.33
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars